7O18

N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH I-BET282

This is a non-PDB format compatible entry.

Summary for 7O18

• Entry DOI: 10.2210/pdb7o18/pdb
• Descriptor: Bromodomain-containing protein 4, 1,2-ETHANEDIOL, (R)-4-(8-methoxy-1-(1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole, ... (4 entities in total)
• Functional Keywords: inhibitor, histone, epigenetic reader, bromodomain, brd4, bromodomain containing protein 4, antagonist, transcription
• Biological source: Homo sapiens (Human)
• Total number of polymer chains: 1
• Total formula weight: 15674.05

Authors

Chung, C. (deposition date: 2021-03-28, release date: 2021-10-13)

• Primary citation: Jones, K.L.,Beaumont, D.M.,Bernard, S.G.,Bit, R.A.,Campbell, S.P.,Chung, C.W.,Cutler, L.,Demont, E.H.,Dennis, K.,Gordon, L.,Gray, J.R.,Haase, M.V.,Lewis, A.J.,McCleary, S.,Mitchell, D.J.,Moore, S.M.,Parr, N.,Robb, O.J.,Smithers, N.,Soden, P.E.,Suckling, C.J.,Taylor, S.,Walker, A.L.,Watson, R.J.,Prinjha, R.K.; Discovery of a Novel Bromodomain and Extra Terminal Domain (BET) Protein Inhibitor, I-BET282E, Suitable for Clinical Progression.; J.Med.Chem., 64:12200-12227, 2021; PubMed: 34387088; DOI: 10.1021/acs.jmedchem.1c00855

Experimental method

X-RAY DIFFRACTION (1.7 Å)